EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Sartans and Bisartans: Expanding Therapeutic Horizons Through Broad Receptor Interactions and Repurposing Potential

Errikos Petsas iD, Vasso Apostolopoulos iD, Despoina P Kiouri iD, Konstantinos Kelaidonis, Harry Ridgway, Graham J Moore, Thomas Mavromoustakos iD, Laura Kate Gadanec iD, John M Matsoukas, Christos T Chasapis iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27198883 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Errikos Petsas und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Organic Chemistry, Department of Chemistry, National and Kapodistrian University of Athens, 15771 Athens, Greece. Hauptthemen laut MEDLINE: Drug Repositioning, Angiotensin II Type 1 Receptor Blockers. Die Arbeit nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Angiotensin receptor blockers (ARBs), also known as sartans, are a family of highly selective angiotensin II type 1 receptor antagonists commonly prescribed to individuals with hypertension, heart failure, and chronic kidney disease. Additionally, the discovery and facile synthesis of bisartans, a novel class of ARB antihypertensives, have shown therapeutic promise for cardiovascular diseases. Recent computational and network pharmacology studies have shown a broader receptor interactome, encompassing alpha-adrenergic receptors, and delta- and mu-opioid receptors, highlighting the polypharmacology of ARBs. Herein, we combine molecular docking, molecular dynamics, and protein–protein interaction analyses to characterize the binding profiles of sartans and bisartans, as well as conformational impacts across multiple G-protein-coupled receptors. Emphasis is placed on their potential to modulate receptor desensitization states and influence pathways involved in neuropsychiatric disorders, addiction, viral infections, and cardiovascular diseases. Limitations of current computational approaches are discussed alongside the need for experimental proteomic validation. Collectively, this evidence positions sartans and bisartans as structurally privileged scaffolds for multi-target drug repurposing and precision medicine applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug RepositioningAngiotensin II Type 1 Receptor BlockersHumansAnimalsMolecular Docking SimulationReceptors, G-Protein-CoupledProtein BindingMolecular Dynamics Simulation

Stichwörter der Autor:innen

G-protein-coupled receptorsangiotensin receptor blockersbisartanspolypharmacologysartans

Substanzen

Receptors, G-Protein-CoupledAngiotensin II Type 1 Receptor Blockers

Autor:innen und Institutionen

  • Laboratory of Organic Chemistry, Department of Chemistry, National and Kapodistrian University of Athens, 15771 Athens, Greece.
  • School of Health and Biomedical Sciences, RMIT University, Melbourne, VIC 3000, Australia.
  • NewDrug PC, Patras Science Park, 26504 Patras, Greece.
  • THERAmolecular, LLC., Rodeo, NM 88056, USA.
  • Institute for Sustainable Industries and Liveable Cities, Victoria University, Melbourne, VIC 8001, Australia.
  • Pepmetics Inc., 772 Murphy Place, Victoria, BC V8Y 3H4, Canada.

ORCID-Profile: Errikos Petsas, Vasso Apostolopoulos, Despoina P Kiouri, Thomas Mavromoustakos, Laura Kate Gadanec, Christos T Chasapis

Zitieren

APA

Petsas, E., Apostolopoulos, V., Kiouri, D. P., Kelaidonis, K., Ridgway, H., Moore, G. J., Mavromoustakos, T., Gadanec, L. K., Matsoukas, J. M., & Chasapis, C. T. (2026). Sartans and Bisartans: Expanding Therapeutic Horizons Through Broad Receptor Interactions and Repurposing Potential. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27198883

Vancouver

Petsas E, Apostolopoulos V, Kiouri DP, Kelaidonis K, Ridgway H, Moore GJ, et al. Sartans and Bisartans: Expanding Therapeutic Horizons Through Broad Receptor Interactions and Repurposing Potential. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27198883

BibTeX
@article{Petsas2026,
  author = {Petsas, Errikos and Apostolopoulos, Vasso and Kiouri, Despoina P and Kelaidonis, Konstantinos and Ridgway, Harry and Moore, Graham J and Mavromoustakos, Thomas and Gadanec, Laura Kate and Matsoukas, John M and Chasapis, Christos T},
  title = {Sartans and Bisartans: Expanding Therapeutic Horizons Through Broad Receptor Interactions and Repurposing Potential},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27198883}
}
Kostenlos starten →